Gregor MacRae
Corporate Officer/Principal bij Appledore Wealth Management LLP
Profiel
Gregor MacRae is a Senior Partner at Appledore Wealth Management LLP.
He was a Non-Executive Director at OKYO Pharma Ltd.
from 2019 to 2020 and at Tiziana Life Sciences Ltd.
(United Kingdom) in 2020.
He is a graduate of the University of Birmingham.
Actieve functies van Gregor MacRae
| Bedrijven | Functie | Begin |
|---|---|---|
| Appledore Wealth Management LLP | Corporate Officer/Principal | - |
Eerdere bekende functies van Gregor MacRae
| Bedrijven | Functie | Einde |
|---|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Directeur/Bestuurslid | 18-06-2020 |
| OKYO PHARMA LIMITED | Directeur/Bestuurslid | 10-06-2020 |
Opleiding van Gregor MacRae
| University of Birmingham | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| OKYO PHARMA LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
| Appledore Wealth Management LLP |